164 related articles for article (PubMed ID: 37740873)
1. Vactosertib potently improves anti-tumor properties of 5-FU for colon cancer.
Binabaj MM; Asgharzadeh F; Rahmani F; Al-Asady AM; Hashemzehi M; Soleimani A; Avan A; Mehraban S; Ghorbani E; Ryzhikov M; Khazaei M; Hassanian SM
Daru; 2023 Dec; 31(2):193-203. PubMed ID: 37740873
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of TGF-β signalling in combination with nal-IRI plus 5-Fluorouracil/Leucovorin suppresses invasion and prolongs survival in pancreatic tumour mouse models.
Hong E; Park S; Ooshima A; Hong CP; Park J; Heo JS; Lee S; An H; Kang JM; Park SH; Park JO; Kim SJ
Sci Rep; 2020 Feb; 10(1):2935. PubMed ID: 32076068
[TBL] [Abstract][Full Text] [Related]
3. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
Li S; Tian J; Zhang H; Zhou S; Wang X; Zhang L; Yang J; Zhang Z; Ji Z
Apoptosis; 2018 Jun; 23(5-6):356-374. PubMed ID: 29777330
[TBL] [Abstract][Full Text] [Related]
4. Gypenosides Synergistically Enhances the Anti-Tumor Effect of 5-Fluorouracil on Colorectal Cancer In Vitro and In Vivo: A Role for Oxidative Stress-Mediated DNA Damage and p53 Activation.
Kong L; Wang X; Zhang K; Yuan W; Yang Q; Fan J; Wang P; Liu Q
PLoS One; 2015; 10(9):e0137888. PubMed ID: 26368019
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the Wnt/b-catenin pathway using PNU-74654 reduces tumor growth in in vitro and in vivo models of colorectal cancer.
Amerizadeh F; Rahmani F; Maftooh M; Nasiri SN; Hassanian SM; Giovannetti E; Moradi-Marjaneh R; Sabbaghzadeh R; Shahidsales S; Joudi-Mashhad M; Ghayour-Mobarhan M; Ferns GA; Khazaei M; Avan A
Tissue Cell; 2022 Aug; 77():101853. PubMed ID: 35803035
[TBL] [Abstract][Full Text] [Related]
6. Resistance of colon cancer to 5-fluorouracil may be overcome by combination with chloroquine, an in vivo study.
Sasaki K; Tsuno NH; Sunami E; Kawai K; Hongo K; Hiyoshi M; Kaneko M; Murono K; Tada N; Nirei T; Takahashi K; Kitayama J
Anticancer Drugs; 2012 Aug; 23(7):675-82. PubMed ID: 22561420
[TBL] [Abstract][Full Text] [Related]
7. Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer.
Lee JE; Lee P; Yoon YC; Han BS; Ko S; Park MS; Lee YJ; Kim SE; Cho YJ; Lim JH; Ryu JK; Shim S; Kim DK; Jung KH; Hong SS
Biomed Pharmacother; 2023 Jun; 162():114716. PubMed ID: 37086509
[TBL] [Abstract][Full Text] [Related]
8. Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer.
Choi J; Park J; Cho I; Sheen Y
Radiol Oncol; 2022 Apr; 56(2):185-197. PubMed ID: 35390248
[TBL] [Abstract][Full Text] [Related]
9. Use of STAT6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated Tumorigenesis.
Mendoza-Rodríguez MG; Sánchez-Barrera CÁ; Callejas BE; García-Castillo V; Beristain-Terrazas DL; Delgado-Buenrostro NL; Chirino YI; León-Cabrera SA; Rodríguez-Sosa M; Gutierrez-Cirlos EB; Pérez-Plasencia C; Vaca-Paniagua F; Meraz-Ríos MA; Terrazas LI
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32244885
[TBL] [Abstract][Full Text] [Related]
10. PAR2 Inhibition Enhanced the Sensitivity of Colorectal Cancer Cells to 5-FU and Reduced EMT Signaling.
Quan Q; Zhong F; Wang X; Chen K; Guo L
Oncol Res; 2019 Jul; 27(7):779-788. PubMed ID: 30841957
[TBL] [Abstract][Full Text] [Related]
11. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer.
Yan L; Yu HH; Liu YS; Wang YS; Zhao WH
Cancer Biomark; 2019; 24(2):231-240. PubMed ID: 30689555
[TBL] [Abstract][Full Text] [Related]
12. Combined 5-FU and ChoKα inhibitors as a new alternative therapy of colorectal cancer: evidence in human tumor-derived cell lines and mouse xenografts.
de la Cueva A; Ramírez de Molina A; Alvarez-Ayerza N; Ramos MA; Cebrián A; Del Pulgar TG; Lacal JC
PLoS One; 2013; 8(6):e64961. PubMed ID: 23762272
[TBL] [Abstract][Full Text] [Related]
13. Ethanolic Extract of Traditional Chinese Medicine (TCM) Gamboge Inhibits Colon Cancer
Wang W; Li Y; Chen Y; Chen H; Zhu P; Xu M; Wang H; Wu M; Yang Z; Hoffman RM; Gu Y
Anticancer Res; 2018 Apr; 38(4):1917-1925. PubMed ID: 29599307
[TBL] [Abstract][Full Text] [Related]
14. 5-Fluorouracil Combined with Rutaecarpine Synergistically Suppresses the Growth of Colon Cancer Cells by Inhibiting STAT3.
Yu Z; Chan S; Wang X; Sun R; Wang M; Wang Z; Zuo X; Chen J; Zhang H; Chen W
Drug Des Devel Ther; 2023; 17():993-1006. PubMed ID: 37020802
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-23a antisense enhances 5-fluorouracil chemosensitivity through APAF-1/caspase-9 apoptotic pathway in colorectal cancer cells.
Shang J; Yang F; Wang Y; Wang Y; Xue G; Mei Q; Wang F; Sun S
J Cell Biochem; 2014 Apr; 115(4):772-84. PubMed ID: 24249161
[TBL] [Abstract][Full Text] [Related]
16. EIF3D promotes resistance to 5-fluorouracil in colorectal cancer through upregulating RUVBL1.
Li C; Lu K; Yang C; Du W; Liang Z
J Clin Lab Anal; 2023 Jan; 37(2):e24825. PubMed ID: 36592991
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell-derived exosome-entrapped fluorouracil can enhance its anti-colon cancer effect.
Xu M; Chen Q; Li J; Peng L; Ding L
J BUON; 2020; 25(3):1413-1422. PubMed ID: 32862584
[TBL] [Abstract][Full Text] [Related]
18. Anti-Cancer Effects of Zotarolimus Combined with 5-Fluorouracil Treatment in HCT-116 Colorectal Cancer-Bearing BALB/c Nude Mice.
Chang GR; Kuo CY; Tsai MY; Lin WL; Lin TC; Liao HJ; Chen CH; Wang YC
Molecules; 2021 Aug; 26(15):. PubMed ID: 34361836
[TBL] [Abstract][Full Text] [Related]
19. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
[TBL] [Abstract][Full Text] [Related]
20. Sanguisorba officinalis L. suppresses 5-fluorouracil-sensitive and-resistant colorectal cancer growth and metastasis via inhibition of the Wnt/β-catenin pathway.
Zhang W; Peng C; Yan J; Chen P; Jiang C; Sang S; Yuan Y; Hong Y; Yao M
Phytomedicine; 2022 Jan; 94():153844. PubMed ID: 34785413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
